Next earnings date: 12 Aug 2025
Accuray Incorporated – NASDAQ:ARAY
Accuray Incorporated stock price today
$1.481
-0.34
-19.09%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Accuray Incorporated stock price monthly change
-7.11%
month
Accuray Incorporated stock price quarterly change
-7.11%
quarter
Accuray Incorporated stock price yearly change
-39.20%
year
Accuray Incorporated key metrics
Market Cap | 183.61M |
Enterprise value | 427.13M |
P/E | -21.71 |
EV/Sales | 1.02 |
EV/EBITDA | 223.86 |
Price/Sales | 0.68 |
Price/Book | 5.55 |
PEG ratio | -1.26 |
EPS | -0.12 |
Revenue | 447.50M |
EBITDA | 946K |
Income | -11.75M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -2.83% |
Oper. margin | 0.55% |
Gross margin | 37.22% |
EBIT margin | 0.55% |
EBITDA margin | 0.21% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAccuray Incorporated stock price history
Accuray Incorporated stock forecast
Accuray Incorporated financial statements
| Jun 2022 | 110.02M | -3.45M | -3.14% |
|---|---|---|---|
| Mar 2023 | 118.06M | 599K | 0.51% |
| Jun 2023 | 118.29M | -2.55M | -2.16% |
| Mar 2024 | 101.13M | -6.34M | -6.27% |
| Sep 2025 | 114.46M | 1.41M | 1.24% |
|---|---|---|---|
| Oct 2025 | 105.21M | 1.17M | 1.11% |
| Dec 2025 | 112.76M | 2.25M | 2% |
| Mar 2026 | 130.70M | 4.30M | 3.29% |
Analysts Price target
Financials & Ratios estimates
| 2024-08-14 | 0.0275 | 0.03 |
|---|---|---|
| 2024-11-06 | -0.03212 | -0.04 |
| Dec 2022 | 468769000 | 417.02M | 88.96% |
|---|---|---|---|
| Mar 2023 | 475720000 | 421.01M | 88.5% |
| Jun 2023 | 479214000 | 425.55M | 88.8% |
| Mar 2024 | 462527000 | 421.44M | 91.12% |
| Jun 2022 | -4.64M | -1.39M | 141K |
|---|---|---|---|
| Mar 2023 | 24.62M | -1.89M | -1.5M |
| Jun 2023 | 8.88M | -7.97M | -522K |
| Mar 2024 | -8.10M | -795K | -1.5M |
Accuray Incorporated alternative data
| Aug 2023 | 1,044 |
|---|---|
| Sep 2023 | 1,044 |
| Oct 2023 | 1,024 |
| Nov 2023 | 1,024 |
| Dec 2023 | 1,024 |
| Jan 2024 | 1,024 |
| Feb 2024 | 1,024 |
| Mar 2024 | 1,024 |
| Apr 2024 | 1,024 |
| May 2024 | 1,024 |
| Jun 2024 | 1,024 |
| Jul 2024 | 1,024 |
Accuray Incorporated other data
44.72%
-16.43%
of ARAY is owned by hedge funds
71
-33
42.28M
-14.90M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Oct 2023 | 0 | 43664 |
| Nov 2023 | 0 | 38338 |
| Dec 2023 | 0 | 157252 |
| Jan 2024 | 0 | 16245 |
| Mar 2024 | 0 | 11991 |
| May 2024 | 100000 | 0 |
| Jun 2024 | 0 | 2701 |
| Sep 2024 | 0 | 8404 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | PERVAIZ ALI officer: SVP Chief Financial Of.. | Common Stock | 8,404 | $2.06 | $17,279 | ||
Sale | PERVAIZ ALI officer: SVP Chief Financial Of.. | Common Stock | 2,701 | $1.7 | $4,597 | ||
Purchase | WHITTERS JOSEPH E director | Common Stock | 50,000 | $1.58 | $79,000 | ||
Purchase | WHITTERS JOSEPH E director | Common Stock | 50,000 | $1.54 | $77,050 | ||
Sale | HOGE MICHAEL officer: Senior VP Global Opera.. | Common Stock | 11,991 | $2.59 | $31,057 | ||
Sale | PERVAIZ ALI officer: SVP Chief Financial Of.. | Common Stock | 2,116 | $2.74 | $5,800 | ||
Sale | CORRADETTI GINA officer: VP, CAO and Controller | Common Stock | 14,129 | $2.74 | $38,728 | ||
Sale | SPINE PATRICK officer: SVP, Chi.. | Common Stock | 14,832 | $2.47 | $36,650 | ||
Sale | WINTER SUZANNE C officer: President | Common Stock | 65,390 | $2.47 | $161,644 | ||
Sale | PERVAIZ ALI officer: SVP Chief Financial Of.. | Common Stock | 13,463 | $2.47 | $33,267 |
| Patent |
|---|
Application Filling date: 14 Apr 2022 Issue date: 4 Aug 2022 |
Application Filling date: 13 Apr 2022 Issue date: 28 Jul 2022 |
Grant Filling date: 6 Nov 2020 Issue date: 12 Jul 2022 |
Grant Filling date: 26 Jul 2016 Issue date: 12 Jul 2022 |
Application Filling date: 16 Mar 2022 Issue date: 30 Jun 2022 |
Grant Utility: Field replaceable, disposable, and thermally optimized X-ray target with integral beam current monitoring Filling date: 27 Jul 2020 Issue date: 28 Jun 2022 |
Grant Filling date: 19 Dec 2019 Issue date: 14 Jun 2022 |
Grant Filling date: 13 Oct 2020 Issue date: 17 May 2022 |
Grant Filling date: 19 Jan 2018 Issue date: 17 May 2022 |
Grant Utility: Using a rotating 2D x-ray imager as an imaging device to perform target tracking during radiation treatment delivery Filling date: 14 Aug 2020 Issue date: 10 May 2022 |
| Quarter | Transcript |
|---|---|
| Q3 2024 1 May 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 31 Jan 2024 | Q2 2024 Earnings Call Transcript |
| Q1 2024 7 Nov 2023 | Q1 2024 Earnings Call Transcript |
| Q2 2023 9 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Joshua H. Levine (1958) Chief Executive Officer & Director | $1,610,000 |
Ms. Suzanne Winter M.B.A. (1963) Pres | $821,650 |
| Mr. Patrick R. Spine (1971) Senior Vice President & Chief Admin. Officer | $632,700 |
| Mr. Jesse Chew (1981) Senior Vice President, Gen. Counsel & Corporation Sec. | $621,120 |
Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp
With Chinese Type B Approval In Hand, 'Now Or Never' Approaches For Accuray
Accuray Incorporated - Impressive Growth As Orders Expands
Accuray Achieves Record Product Revenue, But There's Much Work Still To Be Done
More Progress Evident At Accuray, But Sustainability And Follow-Through Remain Key
More 'Hurry Up And Wait' For Accuray, But The China Opportunity Is Coming Through
-
What's the price of Accuray Incorporated stock today?
One share of Accuray Incorporated stock can currently be purchased for approximately $1.48.
-
When is Accuray Incorporated's next earnings date?
Accuray Incorporated is estimated to report earnings on Tuesday, 12 Aug 2025.
-
Does Accuray Incorporated pay dividends?
No, Accuray Incorporated does not pay dividends.
-
How much money does Accuray Incorporated make?
Accuray Incorporated has a market capitalization of 183.61M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.24% to 446.55M US dollars. Accuray Incorporated made a loss 15.55M US dollars in net income (profit) last year or -$0.04 on an earnings per share basis.
-
What is Accuray Incorporated's stock symbol?
Accuray Incorporated is traded on the NASDAQ under the ticker symbol "ARAY".
-
What is Accuray Incorporated's primary industry?
Company operates in the Healthcare sector and Medical - Specialties industry.
-
How do i buy shares of Accuray Incorporated?
Shares of Accuray Incorporated can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Accuray Incorporated's key executives?
Accuray Incorporated's management team includes the following people:
- Mr. Joshua H. Levine Chief Executive Officer & Director(age: 67, pay: $1,610,000)
- Ms. Suzanne Winter M.B.A. Pres(age: 62, pay: $821,650)
- Mr. Patrick R. Spine Senior Vice President & Chief Admin. Officer(age: 54, pay: $632,700)
- Mr. Jesse Chew Senior Vice President, Gen. Counsel & Corporation Sec.(age: 44, pay: $621,120)
-
How many employees does Accuray Incorporated have?
As Jul 2024, Accuray Incorporated employs 1,024 workers.
-
When Accuray Incorporated went public?
Accuray Incorporated is publicly traded company for more then 18 years since IPO on 8 Feb 2007.
-
What is Accuray Incorporated's official website?
The official website for Accuray Incorporated is accuray.com.
-
Where are Accuray Incorporated's headquarters?
Accuray Incorporated is headquartered at 1240 Deming Way, Madison, WI.
-
How can i contact Accuray Incorporated?
Accuray Incorporated's mailing address is 1240 Deming Way, Madison, WI and company can be reached via phone at +60 88 242 800.
Accuray Incorporated company profile:
Accuray Incorporated
accuray.comExchange:
NASDAQ
Full time employees:
987
Industry:
Medical - Specialties
Sector:
Healthcare
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
1240 Deming Way
Madison, WI 53717-1954
Madison, WI 53717-1954
CIK: 0001138723
ISIN: US0043971052
CUSIP: 004397105
